HomeAmgen dives deeper into rare disease drugs with $27.8 billion Horizon dealFILE PHOTO: An Amgen sign is seen at the company’s

FILE PHOTO: An Amgen sign is seen at the company’s

FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. The biopharmaceutical company reports earnings on Tuesday. REUTERS/Robert Galbraith/File Photo
- Advertisment -
Google search engine

Most Read